Therapy could keep cancer at bay

AN innovative treatment harnessing the immune system could help patients with a deadly form of skin cancer live longer, research suggests. Almost one in five with advanced melanoma survived for five years after receiving lifileucel. A trial found tumours shrank in most cases. The therapy isolates

- By Storm Newton

T cells — a type of white blood cell — from tumours. Growing the cells in a lab before infusing them back into the body allows the immune system to recognise and fight the cancer